Related Experiment Video
Updated: Nov 11, 2025
08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
6.6K
Simplified Dosing Regimens for Gentamicin in Neonatal Sepsis
S D'Agate1, F Tshinanu Musuamba1, E Jacqz-Aigrain2
1Clinical Pharmacology and Therapeutics Group, University College London, London, United Kingdom.
Frontiers in Pharmacology
|March 25, 2021
Summary
A simplified fixed-dose gentamicin regimen for neonatal sepsis is proposed, offering a more rational approach than current weight-based dosing. This method optimizes antibiotic exposure in resource-limited settings for infants aged 0-59 days.
Area of Science:
- Pharmacology
- Neonatal Medicine
- Infectious Diseases
Background:
- Antibiotic effectiveness for neonatal infections in resource-limited settings relies on empirical evidence.
- Current dosing strategies may not ensure optimal antibiotic exposure due to unique neonatal pharmacokinetics.
- Gentamicin pharmacokinetics vary significantly with body size and organ maturation in neonates.
Purpose of the Study:
- To evaluate a simplified gentamicin dosing regimen for neonatal sepsis.
- To account for body size and organ maturation effects on gentamicin pharmacokinetics.
- To support a simplified regimen with clinical trial efficacy data.
Main Methods:
- Utilized a pharmacokinetic model to simulate gentamicin concentrations in virtual neonates.
- Validated model performance with external therapeutic drug monitoring data.
- Conducted clinical trial simulations for intramuscular gentamicin q.d. regimen exposure.
Main Results:
- Proposed a fixed-dose gentamicin regimen based on three weight bands: 10 mg (<2.5 kg), 16 mg (2.5-4 kg), and 30 mg (>4 kg).
- This contrasts with current World Health Organization guidelines recommending 5-7.5 mg/kg.
- The simplified regimen aims to achieve appropriate peak and trough drug levels.
Conclusions:
- Antibiotic dosing requires a strong scientific rationale, considering population-specific drug disposition.
- A simplified gentamicin regimen is feasible for treating sepsis in neonates and young infants.
- This approach could improve antibiotic therapy in resource-limited settings.
Related Concept Videos
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
80
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
80
01:20Estimation of k and VD of Aminoglycosides
62
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
62
01:29Drug Dosing: Infants and Children
87
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
87
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
76
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
76
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
48
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
48
01:28Dosage Regimens: Designs and Approaches
109
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
109